ANRO Competitors & Alternatives
Compare Alto Neuroscience, Inc. with similar stocks in the same industry
Biotechnology
ANRO
Main Stock$22.98
Tradestie Score
51
Market Cap
$110.20M
Analyst Upside
+53.4%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SEPN
Septerna, Inc. Common Stock
|
$26.95
|
$847.12M | - | 59 | Compare |
|
XNCR
Xencor, Inc.
|
$11.22
|
$843.75M | - | 50 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$21.39
|
$841.74M | - | 60 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$37.02
|
$832.47M | - | 53 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$28.78
|
$824.20M | - | 61 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$5.44
|
$821.84M | - | 52 | Compare |
|
EVMN
EVMN
|
$22.92
|
$818.34M | - | 48 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$32.45
|
$800.41M | - | 53 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$3.45
|
$799.70M | - | 54 | Compare |
|
KURA
Kura Oncology, Inc.
|
$9.22
|
$798.53M | - | 59 | Compare |
More ANRO Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry